Impact BioMedical Inc. Common Stock (IBO)

About IBO

Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflamma…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

2

Website

www.impactbiomedinc.com/

Fundamentals

1-day range

$0.442$0.4533

Market cap

$48.61M

P/E (trailing)

0.52

P/E (forward)

—

EPS (trailing)

$-1.26

Dividend yield

—

Beta

-1.23

Avg. volume

53.5K

Impact BioMedical Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• IBO

  Impact BioMedical Inc. Common Stock

  $0.444

  ▲ 0.68%
  Market cap $48.61MP/E 0.52
  $0.37$0.83
• TCRT

  Alaunos Therapeutics Inc. Common Stock

  $1.56

  ▼ 6.02%
  Market cap $48.60MP/E —
  $1.62$4.59
• MREO

  Mereo BioPharma Group plc American Depositary Shares

  $0.2545

  ▼ 6.43%
  Market cap $47.46MP/E —
  $0.2$2.37
• CNTX

  Context Therapeutics Inc. Common Stock

  $0.3836

  ▼ 7.79%
  Market cap $46.31MP/E —
• SCYX

  SCYNEXIS Inc. Common Stock

  $5.44

  ▼ 1.45%
  Market cap $51.64MP/E —
  $3.53$10.48
• RNXT

  RenovoRx Inc. Common Stock

  $1.68

  ▲ 13.18%
  Market cap $51.86MP/E —
  $0.7006$1.56
• SDEV

  Stablecoin Development Corporation Common Stock

  $0.93

  ▼ 5.10%
  Market cap $52.64MP/E —
  $0.96$99.75

P/E shows — for peers not currently carrying a live signal of their own.

• Todd D. Macko · March 27, 2026 · Sale

  43.4K @ $0.5615
• Todd D. Macko · March 25, 2026 · Sale

  1.6K @ $0.6008
• Jason Grady · March 23, 2026 · Sale

  50.0K @ $0.6501

Institutional Ownership

March 31, 2026

Total shares held

3.10M

Total value held

$1.86M

Institutional holders

19